Financials
Income statement
Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
---|---|---|---|---|
Total reported revenue | 15.0B | 11.9B | 13.0B | 14.2B |
Cost of revenue | 8.7B | 8.5B | 10.8B | 10.7B |
Gross profit | 6.4B | 3.4B | 2.2B | 3.6B |
Operating expense | ||||
Research & development | — | — | — | — |
Selling general and admin | — | — | — | — |
Other operating expenses | 1.6B | 1.1B | 795.9M | 979.3M |
Operating income | 3.2B | 801.6M | 58.9M | 1.2B |
Non operating interest income | ||||
Income | — | — | — | — |
Expense | 304.5M | 69.4M | 200.3M | 360.3M |
Other income expense | — | — | — | — |
Pretax income | 3.1B | 890.2M | 591.5M | 1.0B |
Tax provision | 825.8M | 185.5M | -80.2M | 322.2M |
Net income | 2.3B | 704.7M | 671.8M | 701.5M |
Basic EPS | — | 3.5 | 3.3 | 3.5 |
Diluted EPS | — | 3.5 | 3.3 | 3.5 |
Basic average shares | — | 201.9M | 201.7M | 201.6M |
Diluted average shares | — | 202.5M | 202.9M | 202.2M |
EBITDA | 3.9B | 1.4B | 1.2B | 1.8B |
Net income from continuing op. | — | — | — | — |
Minority interests | — | — | — | — |
Preferred stock dividends | 0 | 0 | 0 | 0 |